Helus Pharma

Contributing Author

Recent Articles by Helus Pharma

Jun-29	Helus Pharma Reports Recent Business Highlights and Fiscal Year 2026 Financial Results HELP +6.17% GlobeNewswire
Jun-25	Helus Pharma Announces Closing of US$50 Million Underwritten Offering HELP +18.27% GlobeNewswire
Jun-24	Helus Pharma Announces US$50 Million Underwritten Offering HELP GlobeNewswire
Jun-24	Helus Pharma Provides Update on APPROACH Phase 3 Trial Enrollment Progress HELP GlobeNewswire
Jun-11	Helus Pharma to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Conference HELP GlobeNewswire
Jun-01	Helus Pharma to Participate in the Jefferies Global Healthcare Conference in New York HELP GlobeNewswire
Apr-30	CORRECTION: Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health HELP +8.15% GlobeNewswire
Apr-30	Helus Pharma to Participate at the 29th Annual Milken Institute Global Conference HELP +8.15% GlobeNewswire
Apr-28	Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health HELP GlobeNewswire
Apr-23	Helus Pharma Strengthens Scientific Advisory Board with Addition of Dr. Robert Langer and Dr. Stephen Brannan HELP GlobeNewswire
Apr-20	Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions HELP GlobeNewswire
Apr-20	Helus Pharma Announces Chief Executive Officer Transition; Eric So to Resume Role as Interim Chief Executive Officer HELP GlobeNewswire
Apr-16	Helus Pharma Strengthens Medical Leadership by Appointing Dr. Ken Kramer as Senior Vice President, Medical Affairs HELP GlobeNewswire
Mar-12	Helus Pharma Strengthens Executive Team with Appointment of Jill Conwell as Chief People Officer HELP GlobeNewswire
Mar-05	Helus Pharma Announces Topline Results in Phase 2 Signal Detection Study for HLP004 in Patients with Generalized Anxiety Disorder HELP -33.88% GlobeNewswire
Feb-24	Helus Pharma Appoints Former Pfizer Chief Medical Officer Dr. Freda Lewis-Hall to Board of Directors & Chair of the Scientific Advisory Committee HELP +9.51% GlobeNewswire
Feb-17	Nature Medicine Publishes Helus Pharma's Randomized, Placebo-Controlled Phase 2a Trial of SPL026 in Major Depressive Disorder HELP +11.00% GlobeNewswire
Feb-13	HELUS Pharma Reports Third Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights HELP GlobeNewswire
Feb-10	Helus Pharma Appoints Michael Cola as Chief Executive Officer to Lead Next Phase of Scale and Execution HELP GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)